Corporate & Investor Presentation

Q2 FY22 financial results Diversified revenue by business & by geography OOH SaaS 11% $ in millions, except per share amounts Revenue Non-GAAP gross margin* Non-GAAP operating income* Non-GAAP EPS* * Refer to Non-GAAP reconciliations in the Appendix. 2Q22 $894.9 +12%, +13% CC 57.6% (230) bps $267.7 +5% $1.47 +4% Masks & Other 38% Europe, Asia, and Other 35% Revenue by business 2Q22 Revenue by region 2Q22 Devices 51% U.S., Canada, and Latin America 54% 28 2022 ResMed | Corporate & Investor Presentation - updated 27JAN22 OOH SaaS 11% ResMed

View entire presentation